ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Adaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plc is an active company incorporated on 3 December 2014 with the registered office located in Abingdon, Oxfordshire. Adaptimmune Therapeutics Plc was registered 11 years ago.
Status
Active
Active since incorporation
Company No
09338148
Public limited company
Age
11 years
Incorporated 3 December 2014
Size
Large
Turnover is over £54M
Over 250 employees
Confirmation
Submitted
Dated 18 September 2025 (2 months ago)
Next confirmation dated 18 September 2026
Due by 2 October 2026 (9 months remaining)
Last change occurred 2 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 June 2026 (6 months remaining)
Address
60 Jubilee Avenue
Milton Park
Abingdon
Oxfordshire
OX14 4RX
England
Same address for the past 8 years
Telephone
01235430000
Email
Available in Endole App
People
Officers
4
Shareholders
1
Controllers (PSC)
-
Director • Secretary • British • Lives in England • Born in Mar 1980
Director • British • Lives in United States • Born in Aug 1964
Director • American • Lives in United States • Born in Oct 1949
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Adaptimmune Limited
Christopher James Hill is a mutual person.
Active
Trucs Therapeutics Limited
Christopher James Hill is a mutual person.
Active
CJH Financial Ltd
Christopher James Hill is a mutual person.
Active
Connexin Therapeutics Group Limited
Christopher James Hill is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£72.79M
Decreased by £40.23M (-36%)
Turnover
£142.19M
Increased by £94.87M (+201%)
Employees
486
Increased by 47 (+11%)
Total Assets
£196.81M
Decreased by £27.86M (-12%)
Total Liabilities
-£186.39M
Decreased by £4.5M (-2%)
Net Assets
£10.41M
Decreased by £23.36M (-69%)
Debt Ratio (%)
95%
Increased by 9.74% (+11%)
Latest Activity
Mr Christopher James Hill Appointed
23 Days Ago on 14 Nov 2025
Adrian George Rawcliffe Resigned
23 Days Ago on 14 Nov 2025
David Morrell Mott Resigned
23 Days Ago on 14 Nov 2025
Kristen Hege Resigned
23 Days Ago on 14 Nov 2025
John Paul Furey Resigned
23 Days Ago on 14 Nov 2025
Ali Behbahani Resigned
23 Days Ago on 14 Nov 2025
Priti Hegde Resigned
23 Days Ago on 14 Nov 2025
Andrew Roger Allen Resigned
23 Days Ago on 14 Nov 2025
Mr Christopher James Hill Appointed
23 Days Ago on 14 Nov 2025
William Charles Bertrand Resigned
23 Days Ago on 14 Nov 2025
Get Credit Report
Discover Adaptimmune Therapeutics Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Andrew Roger Allen as a director on 14 November 2025
Submitted on 17 Nov 2025
Appointment of Mr Christopher James Hill as a director on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of Priti Hegde as a director on 14 November 2025
Submitted on 17 Nov 2025
Appointment of Mr Christopher James Hill as a secretary on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of Ali Behbahani as a director on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of John Paul Furey as a director on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of Kristen Hege as a director on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of William Charles Bertrand as a secretary on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of David Morrell Mott as a director on 14 November 2025
Submitted on 17 Nov 2025
Termination of appointment of Adrian George Rawcliffe as a director on 14 November 2025
Submitted on 17 Nov 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year